Načítá se...
Getting personal with myelodysplastic syndromes: is now the right time?
INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and guide therapy decisions. Next generation sequencing (...
Uloženo v:
| Vydáno v: | Expert Rev Hematol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540985/ https://ncbi.nlm.nih.gov/pubmed/30977414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1592673 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|